Beibei Tian

Title: Beibei Tian: Innovator in Pharmaceutical Chemistry

Introduction

Beibei Tian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors for bruton tyrosine kinase (BTK). His work is characterized by a focus on improving the stability and purity of pharmaceutical compounds.

Latest Patents

Beibei Tian holds a patent for a "Crystal form of key intermediate of bruton tyrosine kinase (BTK) inhibitor and preparation method thereof." This patent describes a crystal form II of (R)-1-(1-(tert-butyloxyl)pyrrolidine-3-yl)-3-cyano-4-(4-(2,6-difluorophenoxyl)phenyl)-1H-pyrrole-2-ethyl formate. The crystal form exhibits excellent chemical stability and is convenient for storage and transportation. The preparation process is straightforward and suitable for industrial production, yielding a highly purified sample with a purity of 99.7%. This innovation is crucial for the quality control of BTK inhibitors.

Career Highlights

Beibei Tian is currently employed at Shanghai Zaiqi Bio-tech Co., Ltd. His work at the company focuses on the development of pharmaceutical intermediates and their applications in drug formulation. His expertise in the field has led to advancements in the production of stable and effective pharmaceutical compounds.

Collaborations

Beibei Tian collaborates with several professionals in his field, including Chao Li and Peng Sun. These collaborations enhance the research and development efforts at Shanghai Zaiqi Bio-tech Co., Ltd., contributing to the advancement of pharmaceutical innovations.

Conclusion

Beibei Tian is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in the development of BTK inhibitors. His contributions are vital for improving the quality and stability of pharmaceutical products.